QIAGEN Plans To Achieve At Least 31% CER Adjusted Operating Income Margin In 2028; Plans To Return At Least $1B To Shareholders From 2024-2028
Portfolio Pulse from Benzinga Newsdesk
QIAGEN has announced its 2028 targets, aiming for a 31% CER adjusted operating income margin and plans to return at least $1 billion to shareholders from 2024-2028. The company also targets $2 billion in annual sales by 2028 through new product launches and investments.
June 17, 2024 | 11:42 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
QIAGEN aims for a 31% CER adjusted operating income margin by 2028 and plans to return at least $1 billion to shareholders from 2024-2028. The company also targets $2 billion in annual sales by 2028 through new product launches and investments.
The announcement of ambitious financial targets and a significant return to shareholders is likely to positively impact QIAGEN's stock price in the short term. Investors may view the company's commitment to growth and shareholder returns favorably.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100